Pharmaceutical Industry Analysis and Statistics (since 2008

The Indian Pharmaceutical Manufacturers ReportDo you know....The top 7 best trading partners in the industry?Which company has the highest sales growth?Which companies have the highest levels of debt?This report is an in-depth financial evaluation of the Indian Pharmaceutical Manufacturers Industry. ...

Industries : Pharmaceutical

Worlwide Pharmaceuticals Industry Report

$ 1 313
September 2009

The Global Pharmaceuticals Industry ReportDo you know....The top 7 best trading partners in the industry?Which company has the highest sales growth?Which companies have the highest levels of debt?This report is an in-depth financial evaluation of the global Pharmaceuticals industry. Using the unique ...

Industries : Pharmaceutical

Top 100 Pharmaceutical Manufacturers Industry Analysis

$ 1 313
September 2009

The Global Top 100 Pharmaceutical Industry ReportDo you know....The top 7 best trading partners in the industry?Which company has the highest sales growth?Which companies have the highest levels of debt?This report is an in-depth financial evaluation of the Global Top 100 Pharmaceutical Industry. Us ...

Industries : Pharmaceutical

Top 50 Pharmaceutical Companies Report

$ 1 125
September 2009

The Global Top 50 Pharmaceutical Companies ReportDo you know....The top 7 best trading partners in the industry?Which company has the highest sales growth?Which companies have the highest levels of debt?This report is an in-depth financial evaluation of the Global Top 50 Pharmaceutical Companies. Us ...

Industries : Pharmaceutical

Japan Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

In the Q409 update of BMI?s Japan Pharmaceuticals & Healthcare report, we have introduced our 10-year Drug Expenditure Forecast Model. This proprietary tool reveals that medicine sales in the Asiancountry will decline from US$85.8bn in 2008 to US$84.6bn in 2018. However, in local currency terms,the ...

Industries : Healthcare, Pharmaceutical

Taiwan Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

The overall Taiwanese pharmaceutical and healthcare market will experience an unspectacular, yetsteady, growth over the forecast period. Between 2009 and 2013, BMI forecasts that the drug market willgrow from a value of US$3.63bn to reach US$4.55bn, representing a compound annual growth rate(CAGR) o ...

Industries : Healthcare, Pharmaceutical

Thailand Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

For the Q4 2009 update of BMI?s Thailand Pharmaceuticals & Healthcare Report, we have extended ourforecasts for prescription pharmaceuticals, patented products, generic drugs and over-the-counter (OTC)medicines through to 2018. The South East Asian country?s US$3.52bn pharmaceutical market isproject ...

Industries : Healthcare, Pharmaceutical

Kazakhstan Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

BMI maintains its conservative five-year forecast for the Kazakhstani pharmaceutical market in view ofthe country?s continued macroeconomic challenges as well as growing protectionism in thepharmaceutical sector. Still, barring further devaluation of the tenge vis-à-vis the US dollar in 2009, or as ...

Industries : Healthcare, Pharmaceutical

Kuwait Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

We expect Kuwait?s total drug market to increase in value from US$377mn in 2008 to US$484mn by2013, representing a CAGR of 5.15% in US dollar terms. Per-capita spending on pharmaceuticals willreach US$142 by this point, which is still comparatively low for the Middle East region. Total healthcarespe ...

Industries : Healthcare, Pharmaceutical

Global Medical Devices Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery

$ 2 000
September 2009

Summary?Global Medical Devices Industry Outlook to 2010: Marketing & Sales Strategies and the Impact of Recession and Recovery? is a new report published in association with ICD Research that analyzes how medical equipment manufacturer's media spend, marketing and sales strategies & practices and ...

Industries : Healthcare, Pharmaceutical

Greece Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

It has been a mixed year so far for the Greek pharmaceutical market. Although the sector is outperformingall other domestic manufacturing sectors in 2009, according to data from the NationalStatistics Service of Greece, there are warning signs ahead. Over the first six months of 2009, both theproduc ...

Industries : Healthcare, Pharmaceutical

Moldova Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

Having previously been regarded as the fourth least attractive of the 20 major pharmaceutical market inthe region, Moldova is now placed in a more favourable 15th position in BMI?s Q409 BusinessEnvironment Ranking (BER) table for Emerging Europe. However, this improvement, which bringsMoldova?s plac ...

Industries : Healthcare, Pharmaceutical

Romania Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

In BMI?s Business Environment Ratings for Q409, Romania has moved up two places on the rankingstable to reach fourth position among the 20 Central and Eastern European (CEE) key markets surveyed asa part of BMI?s Pharmaceuticals & Healthcare Business Environment Rankings. Romania?s currentposition ...

Industries : Healthcare, Pharmaceutical

Switzerland Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

Switzerland?s CHF5.9bn (US$5.4bn) drug market has so far avoided the worst effects of the globalfinancial crisis, growing by around 4% in Swiss francs in 2008, However, the next five years are likely tosee markedly slower growth. It is expected that the Swiss drug market will be worth CHF6.6bn in 20 ...

Industries : Healthcare, Pharmaceutical

Ukraine Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

In line with the collapse of the broader Ukrainian economy, BMI expects the US dollar value of thepharmaceutical market to contract massively ? by 37.6% ? by the end of 2009. The good news for theindustry is that the economy is expected to begin to recover in 2010, and the market is forecast to post ...

Industries : Healthcare, Pharmaceutical

Singapore Pharmaceuticals and Healthcare Report Q4 2009

$ 495
September 2009

Singapore now represents an average proposition for multinational pharmaceutical companies operatingin Asia Pacific, behind established leaders such as Japan and South Korea. The country slipped fromfourth in BMI?s Q209 regional Business Environment Rankings (BER) matrix to sixth in Q309 andfurther ...

Industries : Healthcare, Pharmaceutical

China Pharmaceutical Logistics Industry Report, 2009

$ 1 400
September 2009

In recent years, China pharmaceutical logistics industry has changed fundamentally, which is reflected in the accomplished or ongoing logistics projects. Large-scale pharmaceutical distribution centers supported by T-bond discount loans have been founded and many small and medium-size pharmaceutical ...

Industries : Pharmaceutical

World Neurodegenerative Diseases Market 2009-2024

$ 2 501
September 2009

Rising neurodegenerative disease prevalence and expanding patent populations - where are the best opportunities and how can you unlock these? Our new report - World Neurodegenerative Diseases Market 2009-2024 - explains.The ageing of the baby-boom generation, combined with new and emerging treatment ...

Industries : Pharmaceutical

Nutraceuticals Market - India

$ 400
September 2009

Total market for Nutraceuticals in India is valued at INR 44 bn in 2009; it is estimated to reach INR 95 bn in 2013. Market comprises of two segments - Food Supplements and Vitamins & Minerals. The report provides a snapshot of the market including its segments food supplements, and vitamins and m ...

Industries : Pharmaceutical

Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain integrity

$ 3 835
September 2009

IntroductionParallel trade is a legitimate method of pharmaceutical import and export within the EU zone. Although previously recognized in North America as illegal, cross-border reimportation is now permitted following legislation allowing drugs to be imported into the US from Canada. However, coun ...

Industries : Healthcare, Pharmaceutical

Autoimmune Treatment (2009 - 2014)

$ 4 650
September 2009

REPORT DESCRIPTIONAutoimmune disorders result from an overactive immune response of a body working against its own cells. The disease is broadly classified into two types: systemic autoimmune diseases, which affect several organs of the body; and localized autoimmune diseases, which affect only one ...

Industries : Pharmaceutical

Pharmaceutical Preparation Manufacturing Industry in the U.S. and its International Trade [Q3 2009 Edition]

$ 599
September 2009

The just published Pharmaceutical Preparation Manufacturing Industry report is the comprehensive market research guide on the industry. Its provides the latest information on the industry's key financial data, competitive landscape, cost and pricing, and trends during the current economic recession ...

Industries : Pharmaceutical

Global Economic Downturn: Implications for the Pharmaceutical Industry

$ 769
September 2009

From A Credit Crunch? Following several decades of multilateral efforts to ensure good governance within emerging markets to reduce economic volatility, it is no small irony that the credit crisis originated in the US, the heart of the global economy. Abundant liquidity and a shareholder imperati ...

Industries : Pharmaceutical

Competitor Analysis: EGF-R Agonists and Antagonists

$ 500
September 2009

Product description The present Competitive Intelligence Report about EGF-R agonists and antagonists provides a competitor evaluation in the field of epidermal growth factor receptor (EGF-R; ErbB1) targeting molecules for wound healing or treatment of cancer as of September 2009. Purchase of th ...

Industries : Biotechnology, Pharmaceutical

Competitor Analysis: Her2 Receptor Antagonists

$ 313
September 2009

Product description The present Competitive Intelligence Report about Her2 receptor antagonists provides a competitor evaluation in the field of Her2 (ErbB2) receptor targeting molecules for treatment of cancer as of September 2009. Purchase of the downloadable pdf report includes a 6-month onlin ...

Industries : Biotechnology, Pharmaceutical

Global Generics

$ 250
September 2009

Datamonitor's Global Generics industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and de ...

Industries : Generic Drug

Generics in Asia-Pacific

$ 250
September 2009

Datamonitor's Generics in Asia-Pacific industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading compani ...

Industries : Generic Drug

Generics in Belgium

$ 250
September 2009

Datamonitor's Generics in Belgium industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies an ...

Industries : Generic Drug

Generics in Canada

$ 250
September 2009

Datamonitor's Generics in Canada industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...

Industries : Generic Drug

Generics in China

$ 250
September 2009

Datamonitor's Generics in China industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and ...

Industries : Generic Drug

<<
< Previous
1
2
3
4
5
6
7
8
9
10
100
Next >
>>

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.